Figure 1From: KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer Overall survival by KRAS mutation status in tumor tissue (A) and plasma (B) samples detected by PNA-PCR (see text for further details). Back to article page